EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A compact base editor rescues AATD-associated liver and lung disease in mouse models

Jenny Gao, Nathan Bamidele, Debora Pires-Ferreira, Chunwei Zheng, April Destefano, Haoyang Cheng, Qiushi Tang, Yueying Cao, Jun Xie, Guangping Gao, Alisha Gruntman, Erik Sontheimer und 2 weitere

Molecular Therapy · 2025-11 · 33 (11) · 5817-5828

DOI: 10.1016/j.ymthe.2025.08.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025-11. Verfasst von Jenny Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA. Hauptthemen laut MEDLINE: Gene Editing, alpha 1-Antitrypsin, alpha 1-Antitrypsin Deficiency, Liver Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha-1 antitrypsin deficiency (AATD) is commonly caused by a G-to-A mutation in the SERPINA1 gene (the PiZ mutation). The mutant PiZ AAT protein is sequestered in hepatocytes, causing lung emphysema due to insufficient AAT protein to inhibit neutrophil elastase in the lung. Here, we show that a compact adenine base editor (ABE) with an evolved Cas9 nickase derived from Neisseria meningitidis (eNme2.C) can be packaged in a single AAV and correct the PiZ mutation in mouse models of AATD. An all-in-one eNme2.C-TadA8e/guide 2 plasmid achieved approximately 20% on-target editing in PiZ reporter cells. TadA9e demonstrated sequence-specific reduction in bystander editing compared to TadA8e, without significantly affecting the on-target edit. In PiZ transgenic mice, eNme2.C-TadA9e AAV showed approximately 23% editing efficiency after 8 weeks and reduced liver disease burden in treated mice. In a new AAT-null;PiZ transgenic mouse model, ABE restored serum levels of AAT to beyond the 570 μg/mL therapeutic level. Moreover, ABE treatment was able to significantly correct lung functions in AAT-null;PiZ animals with emphysema. This study demonstrates the feasibility of an eNme2.C-based ABE in a single AAV to treat both AATD-associated liver and lung disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Editingalpha 1-Antitrypsinalpha 1-Antitrypsin DeficiencyLiver DiseasesLung DiseasesGenetic TherapyAnimalsMiceDisease Models, AnimalMice, TransgenicHumansMutationCRISPR-Cas SystemsDependovirusGenetic Vectors

Stichwörter der Autor:innen

AAVbase editinggene editingmouse liverrare diseases

Substanzen

alpha 1-Antitrypsin

Autor:innen und Institutionen

  • RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
  • Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA.
  • Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, MA 01605,…
  • Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Department of Pediatrics, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Department of Cl…
  • RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Department of Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Li Weib…
  • RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA; Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01…

Förderung

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Heart Lung and Blood Institute
  • Friedreich's Ataxia Research Alliance
  • National Institutes of Health

Zitieren

APA

Gao, J., Bamidele, N., Pires-Ferreira, D., Zheng, C., Destefano, A., Cheng, H., Tang, Q., Cao, Y., Xie, J., Gao, G., Gruntman, A., Sontheimer, E., Flotte, T. R., & Xue, W. (2025). A compact base editor rescues AATD-associated liver and lung disease in mouse models. Molecular Therapy, 33(11), 5817-5828. https://doi.org/10.1016/j.ymthe.2025.08.040

Vancouver

Gao J, Bamidele N, Pires-Ferreira D, Zheng C, Destefano A, Cheng H, et al. A compact base editor rescues AATD-associated liver and lung disease in mouse models. Molecular Therapy. 2025;33(11):5817-5828. doi:10.1016/j.ymthe.2025.08.040

BibTeX
@article{Gao2025,
  author = {Gao, Jenny and Bamidele, Nathan and Pires-Ferreira, Debora and Zheng, Chunwei and Destefano, April and Cheng, Haoyang and Tang, Qiushi and Cao, Yueying and Xie, Jun and Gao, Guangping and Gruntman, Alisha and Sontheimer, Erik and Flotte, Terence R and Xue, Wen},
  title = {A compact base editor rescues AATD-associated liver and lung disease in mouse models},
  journal = {Molecular Therapy},
  year = {2025},
  volume = {33},
  number = {11},
  pages = {5817--5828},
  doi = {10.1016/j.ymthe.2025.08.040}
}
Kostenlos starten →